Label-Free, Portable, and Color-Indicating Cholesteric Liquid Crystal Test Kit for Acute Myocardial Infarction by Spectral Analysis and Naked-Eye Observation.
Fu-Lun ChenLi-Dan ShangYen-Chung LinBo-Yen ChangYu-Cheng HsiaoPublished in: Biosensors (2022)
The early diagnosis of acute myocardial infarction is difficult in patients with nondiagnostic characteristics. Acute myocardial infarction with chest pain is associated with increased mortality. This study developed a portable test kit based on cholesteric liquid crystals (CLCs) for the rapid detection of AMI through eye observation at home. The test kit was established on dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride-coated substrates covered by a CLC-binding antibody. Cardiac troponin I (cTnI) is a major biomarker of myocardial cellular injury in human blood. The data showed that the concentration of cTnI was related to light transmittance in a positive way. The proposed CLC test kit can be operated with a smartphone; therefore, it has high potential for use as a point-of-care device for home testing. Moreover, the CLC test kit is an effective and innovative device for the rapid testing of acute myocardial infarction-related diseases through eye observation, spectrometer, or even smartphone applications.
Keyphrases
- acute myocardial infarction
- percutaneous coronary intervention
- left ventricular
- label free
- endothelial cells
- healthcare
- type diabetes
- acute coronary syndrome
- risk factors
- cardiovascular events
- coronary artery disease
- optical coherence tomography
- deep learning
- room temperature
- risk assessment
- induced pluripotent stem cells
- climate change